Literature DB >> 33639944

The role of the gut microbiota on the metabolic status of obese children.

Xin Yuan1, Ruimin Chen2, Kenneth L McCormick3, Ying Zhang1, Xiangquan Lin1, Xiaohong Yang1.   

Abstract

BACKGROUND: The term "metabolically healthy obese (MHO)" denotes a hale and salutary status, yet this connotation has not been validated in children, and may, in fact, be a misnomer. As pertains to obesity, the gut microbiota has garnered attention as conceivably a nosogenic or, on the other hand, protective participator.
OBJECTIVE: This study explored the characteristics of the fecal microbiota of obese Chinese children and adolescents of disparate metabolic statuses, and the associations between their gut microbiota and circulating proinflammatory factors, such as IL-6, TNF-α, lipopolysaccharide-binding protein (LBP), and a cytokine up-regulator and mediator, leptin.
RESULTS: Based on weight and metabolic status, the 86 Chinese children (ages 5-15 years) were divided into three groups: metabolically healthy obese (MHO, n = 42), metabolic unhealthy obese (MUO, n = 23), and healthy normal weight controls (Con, n = 21). In the MUO subjects, the phylum Tenericutes, as well as the alpha and beta diversity, were significantly reduced compared with the controls. Furthermore, Phylum Synergistetes and genus Bacteroides were more prevalent in the MHO population compared with controls. For the MHO group, Spearman's correlation analysis revealed that serum IL-6 positively correlated with genus Paraprevotella, LBP was positively correlated with genus Roseburia and Faecalibacterium, and negatively correlated with genus Lactobacillus, and leptin correlated positively with genus Phascolarctobacterium and negatively with genus Dialister (all p < 0.05).
CONCLUSION: Although there are distinct differences in the characteristic gut microbiota of the MUO population versus MHO, dysbiosis of gut microsystem is already extant in the MHO cohort. The abundance of some metabolism-related bacteria associates with the degree of circulating inflammatory compounds, suggesting that dysbiosis of gut microbiota, present in the MHO children, conceivably serves as a compensatory or remedial response to a surfeit of nutrients.

Entities:  

Keywords:  16s rRNA; Children; Gut microbiota; Metabolically healthy obese

Year:  2021        PMID: 33639944      PMCID: PMC7916301          DOI: 10.1186/s12934-021-01548-9

Source DB:  PubMed          Journal:  Microb Cell Fact        ISSN: 1475-2859            Impact factor:   5.328


  38 in total

1.  Redefining metabolically healthy obesity.

Authors:  Claire Greenhill
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

2.  Obesity and prognosis: Time to forget about metabolically healthy obesity.

Authors:  Xavier Garcia-Moll
Journal:  Eur Heart J       Date:  2018-02-01       Impact factor: 29.983

Review 3.  Defining metabolically healthy obesity in children: a scoping review.

Authors:  S Damanhoury; A S Newton; M Rashid; L Hartling; J L S Byrne; G D C Ball
Journal:  Obes Rev       Date:  2018-08-28       Impact factor: 9.213

Review 4.  Research progress in the relationship between type 2 diabetes mellitus and intestinal flora.

Authors:  Quantao Ma; Yaqi Li; Pengfei Li; Min Wang; Jingkang Wang; Ziyan Tang; Ting Wang; Linglong Luo; Chunguo Wang; Ting Wang; Baosheng Zhao
Journal:  Biomed Pharmacother       Date:  2019-06-24       Impact factor: 6.529

Review 5.  Metabolically healthy versus metabolically unhealthy obesity.

Authors:  Carla Iacobini; Giuseppe Pugliese; Claudia Blasetti Fantauzzi; Massimo Federici; Stefano Menini
Journal:  Metabolism       Date:  2018-11-17       Impact factor: 8.694

Review 6.  Gut microbiota and obesity.

Authors:  Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2015-10-12       Impact factor: 9.261

7.  Novel associations of serum adropin and lipopolysaccharide-binding protein versus lipid profiles in childhood obesity.

Authors:  Xin Yuan; Ruimin Chen; Qian Ouyang; Xiangquan Lin; Zhuanzhuan Ai; Ying Zhang; Xiaohong Yang
Journal:  J Pediatr Endocrinol Metab       Date:  2020-01-18       Impact factor: 1.634

Review 8.  Gut microbial metabolites in obesity, NAFLD and T2DM.

Authors:  Emanuel E Canfora; Ruth C R Meex; Koen Venema; Ellen E Blaak
Journal:  Nat Rev Endocrinol       Date:  2019-05       Impact factor: 43.330

Review 9.  Metabolically Healthy Obesity-Heterogeneity in Definitions and Unconventional Factors.

Authors:  Inês Brandão; Maria João Martins; Rosário Monteiro
Journal:  Metabolites       Date:  2020-01-27

10.  Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children.

Authors:  Luigui Gallardo-Becerra; Fernanda Cornejo-Granados; Rodrigo García-López; Alejandra Valdez-Lara; Shirley Bikel; Samuel Canizales-Quinteros; Blanca E López-Contreras; Alfredo Mendoza-Vargas; Henrik Nielsen; Adrián Ochoa-Leyva
Journal:  Microb Cell Fact       Date:  2020-03-06       Impact factor: 5.328

View more
  5 in total

1.  Composition of Human Breast Milk Microbiota and Its Role in Children's Health.

Authors:  Veronica Notarbartolo; Mario Giuffrè; Claudio Montante; Giovanni Corsello; Maurizio Carta
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-05-09

Review 2.  Gut microbiota in patients with obesity and metabolic disorders - a systematic review.

Authors:  Zhilu Xu; Wei Jiang; Wenli Huang; Yu Lin; Francis K L Chan; Siew C Ng
Journal:  Genes Nutr       Date:  2022-01-29       Impact factor: 5.523

Review 3.  The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management.

Authors:  Ali Nabavi-Rad; Amir Sadeghi; Hamid Asadzadeh Aghdaei; Abbas Yadegar; Sinéad Marian Smith; Mohammad Reza Zali
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 4.  Gut microbiota and COVID-19: An intriguing pediatric perspective.

Authors:  Maria Sole Valentino; Claudia Esposito; Simone Colosimo; Angela Maria Caprio; Simona Puzone; Stefano Guarino; Pierluigi Marzuillo; Emanuele Miraglia Del Giudice; Anna Di Sessa
Journal:  World J Clin Cases       Date:  2022-08-16       Impact factor: 1.534

5.  A Possible Link between Gut Microbiome Composition and Cardiovascular Comorbidities in Psoriatic Patients.

Authors:  Virginia Valentini; Valentina Silvestri; Agostino Bucalo; Federica Marraffa; Maria Risicato; Sara Grassi; Giovanni Pellacani; Laura Ottini; Antonio Giovanni Richetta
Journal:  J Pers Med       Date:  2022-07-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.